Legend Biotech (LEGN) Free Cash Flow (2019 - 2025)

Legend Biotech's Free Cash Flow history runs 7 years deep, the most recent figure standing at -$12.2 million for Q4 2025.

• Quarterly Free Cash Flow rose 88.7% year-over-year to -$12.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$84.0 million (up 46.91% YoY) and the FY2025 annual result came in at -$100.2 million, up 36.62% from the prior year.
• Free Cash Flow was -$12.2 million for Q4 2025 at Legend Biotech, down from $33.8 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $33.8 million in Q3 2025 and bottomed at -$156.3 million in Q4 2021.
• A 5-year average of -$53.3 million and a median of -$44.3 million in 2021 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2023 — Free Cash Flow plunged 909.56% — and 2025, when it soared 145.83%.
• Legend Biotech's Free Cash Flow stood at -$156.3 million in 2021, then jumped by 81.56% to -$28.8 million in 2022, then sank by 356.25% to -$131.5 million in 2023, then advanced by 17.9% to -$107.9 million in 2024, then surged by 88.7% to -$12.2 million in 2025.
• Business Quant data shows LEGN's Free Cash Flow at -$12.2 million in Q4 2025, $33.8 million in Q3 2025, and -$3.8 million in Q2 2025.